organooxygen compound >
oxacycle >
oxanes >
2-[(3s,6as,8s,10as)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-ethylacetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
cyclic compound >
organic cyclic compound >
organic heterocyclic compound >
oxacycle >
oxanes >
2-[(3s,6as,8s,10as)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-ethylacetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic cyclic compound >
organic heterocyclic compound >
oxacycle >
oxanes >
2-[(3s,6as,8s,10as)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-ethylacetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic cyclic compound >
organic heterocyclic compound >
oxacycle >
oxanes >
2-[(3s,6as,8s,10as)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-ethylacetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
cyclic compound >
organic cyclic compound >
organic heterocyclic compound >
organic heteromonocyclic compound >
oxanes >
2-[(3s,6as,8s,10as)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-ethylacetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic cyclic compound >
organic heterocyclic compound >
organic heteromonocyclic compound >
oxanes >
2-[(3s,6as,8s,10as)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-ethylacetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic cyclic compound >
organic heterocyclic compound >
organic heteromonocyclic compound >
oxanes >
2-[(3s,6as,8s,10as)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-ethylacetamide
Preferred term
2-[(3s,6as,8s,10as)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-ethylacetamide
inchi
-
InChI=1S/C19H32N2O6/c1-2-20-18(23)9-15-3-4-16-17(27-15)12-26-11-14(22)10-21(16)19(24)13-5-7-25-8-6-13/h13-17,22H,2-12H2,1H3,(H,20,23)/t14-,15-,16-,17+/m0/s1
inchikey
-
MWTQFHHONBVRQP-LUKYLMHMSA-N
smiles
-
CCNC(=O)C[C@@H]1CC[C@H]2[C@H](O1)COC[C@H](CN2C(=O)C3CCOCC3)O
-
2 [(3S,6aS,8S,10aS) 3 هیدروکسی 1 [4 oxanyl(oxo)methyl] 3,4,6,6a,8,9,10,10a octahydro 2H pyrano[2,3 c][1,5]oxazocin 8 yl] N اتیلاستامی
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:101376
